BOCA RATON, Fla., Dec. 2, 2004 (PRIMEZONE) -- Pure H20 Bio-Technologies, Inc. (Pink Sheets:PHBT) today announced Khandaker Partners, Inc., a New York, N.Y. Equity Research Firm, initiated coverage of Pure H20 Bio-Technologies, Inc. The following Khandaker Equity Research Report is for marketing purposes and consumer awareness. Its content is a based overview report by Khandaker's Medical Doctors who are senior analysts, leaving a transparent unbiased company overview based on merit. Pure H20 Bio-Technologies, Inc., will be enrolled on Khandaker Analytical Review in the near future as it is the premiere investment and business online forum for Health Care, Life Sciences, and Medical Technology. Pure H20 Bio-Technologies will be featured on Khandaker.com along with product profile and investor information that will be maintained on "Investor Central" for the year 2005. Updated postings of all company press releases will also be viewed on Khandaker.com.
Joseph P. Doxey, President of Pure H20 Bio-Technologies, Inc. stated, "We look forward to building a long term working relationship with Khandaker Partners, Inc., utilizing their marketing expertise."
The Company: PHBT is a publicly-held company specializing in the manufacture, design and sale of its unique residential, commercial and hospital systems that combat waterborne disease.
The Khandaker Equity Research Report follows.
Pure H20 Bio-Technologies, Inc.
INDUSTRY: Scientific Instruments
EQUITY RESEARCH November 11, 2004
---------------------------------------------------------------------
Investment highlights
-- Clancy Environmental Consultants (CEC), a nationally
recognized microbiological/water expert, located in St.
Albans, Vermont, on the efficacy of iodine at low
concentrations on three major waterborne bacterial
contaminants. These included Escherichia coli, Enterococcus
faecalis, and Pseudomonas aeruginosa. Treatment with low
concentrations reduced the number of microbes by approximately
6 logs (99.9999% killed) within 5 minutes and 8 logs
(99.999999% killed) within 10 minutes
-- At least 12% of United States households treat their drinking
water in some fashion and industry analysts expect this number
to increase to 40% by the year 2010.
-- The PHBT point-of-entry water treatment systems provide
another layer of protection for individual homes, businesses
and healthcare facilities in the event that municipal
systems...
-- World Health Organization has recommended the consideration of
iodine for the control of cytomegalovarius (CMV) retinitis
which is the most common cause of vision loss in HIV-positive
patients, and that in the absence of effective antiviral
medications, this form of retinitis is uniformly blinding,
i.e., "Povidone-iodine, an inexpensive and broadly acting
anti-infective agent with both antibacterial and antiviral
properties, may hold great promise for the future particularly
in developing countries."
-- PHBT was awarded the sum of $896,619.50 plus 6% interest until
fully paid from the 17th Judicial Circuit, Broward County,
Florida.
Last Trade: 0.025
Trade Time: 11:03AM ET
Change: Down 0.007
(21.88%)
Prev Close: 0.032
Open: 0.035
Bid: N/A
Ask: N/A
1y Target Est: N/A
Day's Range: 0.025 - 0.035
52wk Range: N/A - N/A
Volume: 141,400
Avg Vol (3m): N/A
Market Cap: N/A
P/E (ttm): N/A
EPS (ttm): N/A
Div & Yield: N/A (N/A)
Company description
PHBT is a publicly held company specializing in the manufacturing, design and sale of its unique residential, commercial and hospital point-of-use potable water disinfection systems. These systems are specifically designed to work effectively against water-borne pathogens and remove heavy metals and objectionable biomass.
The PHBT point-of-entry water treatment systems provide another layer of protection for individual homes, businesses and healthcare facilities in the event that municipal systems become compromised with chlorine-resistant etiological agents. Researchers have long recognized the disinfection capability of iodine for over 170 years (Environmental Health Techniques in Rural Areas, Technische Universitat Hambur-Harburg, Germany, 1985 and W. Gottardi, University of Innsbruck, 1999). Historically, the concern has been to deliver the iodine in a manner that does not present a residual in treated potable water supplies. The PHBT technology provides a new water treatment option based on a system designed with both pre-and post-absolute carbon filtration used in combination with direct crystal iodine contact for disinfection.
Moreover, the PHBT system is designed not to release detectable residual halogen into the disinfected water supplies. Both the iodine concentration and the contact time can be controlled independently of pH, and have demonstrated laboratory effective kill rates to a level of log 8 against microbial agents, as recent PHBT's test results confirm. Reminder: The CDC makes no recommendation as to the use of the portable filters on the market due to lack of independently verified results of their efficacy.
Sector
Market segments include residences, retail dispensing, educational facilities, commercial, agriculture, municipal facilitates, military bases, and cruise ships. All will need to be profiled and tested in order to confirm the served market potential. The company PHBT believes that it will be able to compete versus the individual technologies of UV light, granular activated carbon filtration membrane/hollow fiber media, ion exchange resins, silver, chlorine and diatomaceous earth depth filtration systems by virtue of its intellectual property (patents) which stress the safety and efficacy of ozone -iodine -micron disinfecting water purification systems.
Product and Revenues
At least 12% of United States households treat their drinking water in some fashion and industry analysts expect this number to increase to 40% by the year 2010. In an earlier market assessment, health officials estimate that 900,000 people each year become infected with waterborne disease and the General Accounting Office estimates that 66% of Safe Drinking Water Act violations are not reported. These findings, along with the evolution of chlorine-resistant organisms, suggest that the demand for high purity water by end users will continue to increase.
US Markets
Housing Units 119,117,000 U.S. Census Bureau 2001
New cancer cases 1,334,100 ACS-NCI- SEER 2003
Nursing Facilities 17,800 NNH Survey 1998
Hospitals 6,000 American Hospital Association
Military Installations 580 88% domestic bases,
12% Foreign bases
Recreational
Facilities 6,600,000 National SPA & Pool Institute
Technology Advantage
Consumer Knowledge and Awareness:
Log 10 = Log base 10 is the number raised to the power of 10.
Example: 10(1) = 10; 10(2) = 100; etc. and log reduction of 1= 90%
reduction in the number, log of 2 = 99% reduction, and of log
3 = 99.9% reduction, etc.
6 log reduction means 1,000,000 killed
8 log reduction means 100,000,000 killed
Developing Countries
World Health Organization has recommended the consideration of iodine for the control of cytomegalovarius (CMV) retinitis which is the most common cause of vision loss in HIV-positive patients, and that in the absence of effective antiviral medications, this form of retinitis is uniformly blinding, i.e., "Povidone-iodine, an inexpensive and broadly acting anti-infective agent with both antibacterial and antiviral properties, may hold great promise for the future particularly in developing countries."
Biodefense - Etiological Agents Category A Anthrax Botulism Small Pox Viral hemorrhagic fevers Category B Brucellosis Salmonella , Ecoli 0157:H7 , Shigella Staphylococcal Enterotoxin B Vibrio Cholerae Category C Emerging Infectious disease - Hanta virus
Recent Note
PHBT was awarded the sum of $896,619.50 plus 6% interest until fully paid from the 17th Judicial Circuit, Broward County, Florida. The award reflects a unanimous jury verdict against Joseph A. Mazziotti and Louis J. Mazziotti, Kentucky, for Fraud, Breach of Contract and Money Lent and triple damages for Theft under Florida Statute 772.11
Conclusion
There are major players in the residential water treatment business including Chlorox (Brita), Proctor & Gamble (PUR) and Vivendi. The Brita and PUR technologies are mainly designed on porous iodine exchange carbon block filter to reduce microbial contamination of drinking water. Carbon Block filter designs are limited and fail to take into account the wide array of microorganism diameter depending on their lifecycle. None have disinfection capability and most have limited filtration capacities whereas PHBT technology combines the use of absolute micron carbon pre and post filters with controlled release USP iodine to treat waterborne Pathogens and remove heavy metals and objectionable biomass.
Finally Pure H20 Biotechnologies (PHBT) could become a major competitor capitalizing on the omnipresent need for improved point-of-entry water treatment systems.
The foregoing press release contains forward-looking statements that can be identified by such terminology as "expects," potential, "suggests," "may," "will," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations regarding future research, development, and or commercial results could be affected by, among other things, uncertainties relating to the availability of future financing; unexpected regulatory delays or government regulation generally; the company's ability to obtain or maintain patent and other proprietary intellectual property protection; and competition in general. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.